www.cancerindetail.com

Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American...

20 hrs ago | gnom.es

SAN DIEGO , May 23, 2013 /NEWS.GNOM.ES/ -- The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108 th Annual Meeting of the American Urological Association... Read more...

SonaCare UCL HIFU Sonablate ablative minimally Sonatherm invasive UCLB AUA prostate Medical treatment technology SmartTarget ultrasound cancer

image

Sanofi Showcases Commitment to Prostate Cancer Research at Genitourinary Cancer Symposium

5 hrs ago | globalregulatoryscience.com

mia.burns Bridgewater, NJ – February 12, 2013 – Sanofi US today announced that ten company-supported abstracts covering ongoing prostate cancer research will be presented on February 14 and 15 during the 2013 Genitourinary... Read more...

prostate cancer Abstract Oncology metastatic castration-resistant cabazitaxel docetaxel Angelergues NCT01254279 McKessson survival

image

Genomic analysis lends insight to prostate cancer

17 hrs ago | cancerlive.net

"This is the first study to examine DNA alterations using next generation sequencing in adjacent Gleason patterns in the same tumor allowing us to correlate genomics with changes in pathology," says John Cheville, M.D., Mayo... Read more...

Gleason prostate pattern tumor cancer Cheville M.D. Ph.D. pathologist alteration 130523162300.htm sample

image

Mayo Clinic genomic analysis lends insight to prostate cancer

18 hrs ago | eurekalert.org

Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings... Read more...

Gleason Mayo Clinic prostate genomic cancer tumor pattern Cheville M.D. Ph.D. www.mayoclinic.org pathologist analysis

Astellas and Medivation Announce Submission of Application for Marketing Approval of...

5 hrs ago | finanznachrichten.de

Astellas Pharma Inc. (TOKYO: 4503) and Medivation, Inc. (NASDAQ: MDVN) today announced that Astellas has submitted an application for marketing approval of enzalutamide (generic name) to the Ministry of Health, Labour and... Read more...

XTANDI Medivation patient Astellas seizure

image

Quantitative Analysis of Multiparametric Prostate MR Images: Differentiation between Prostate...

17 hrs ago | rsnajnls.org

Purpose: To evaluate the potential utility of a number of parameters obtained at T2-weighted, diffusion-weighted, and dynamic contrast material–enhanced multiparametric magnetic resonance (MR) imaging for computer-aided... Read more...

Yahui Peng ADC MR T2-weighted M.L.G. Y.J. Y.P. Ktrans differentiation A.O. skewness ± C.Y. percentile S.E.E. cancer ROIs I.S. J.B.B. manuscript AUC prostate multiparametric

American Cancer Society celebrates 100 years of progress

24 hrs ago | kfvs12.com

American Cancer Society celebrates 100 years of progress American Cancer Society celebrates 100 years of progress The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a... Read more...
All similar articles: 251 »

cancer Society celebrate American progress organ century disease melanoma 100 prostate

image

MR Imaging-guided Focal Laser Ablation for Prostate Cancer: Phase I Trial [Technical Developments]

17 hrs ago | rsnajnls.org

From the Department of Radiology (A.O., I.S., G.K.), Section of Hematology/Oncology, Department of Medicine (W.M.S.), Department of Health Studies (S.W.), and Section of Urology, Department of Surgery (S.E.), University of... Read more...

Aytekin Oto MR ablation focal M.K.I. laser prostate A.O. imaging cancer SHIM R.M. IPSS S.E. I.S. Transperineal biopsy manuscript G.K. W.M.S. phase

Check the map – medical procedure rates vary widely across California

13 hrs ago | stanford.edu

While many patients may think “doctor knows best” when choosing between different medical procedures, a new study from the California HealthCare Foundation found that some of these decisions may be driven more by local... Read more...

Kris Newby procedure map rate California medical cancer prostate patient elective Stanford breast preference brachytherapy

Molecular Diagnostics in Cancer Testing

May 22, 2013 | sacbee.com

Published: Wednesday, May. 22, 2013 - 11:55 am NEW YORK, May 22, 2013 -- /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:... Read more...

cancer molecular diagnostic table diagnostics testing Biomarkers colon Assay Market

Bee Pollen And Curcumin For Prostatitis

May 23, 2013 | easyhealthoptions.com

Using natural ways to protect your prostate can mean a reduced risk of cancer and less inflammation. But if you want to use items like bee pollen for better prostate health, remember that not all bee pollen may be equally... Read more...

Geo Espinosa pollen curcumin Prostatitis Graminex prostate bee Cernilton supplement

image

This Week in Cell

May 22, 2013 | genomeweb.com

A systems biology-based analysis of postmortem brain samples from individuals with late-onset Alzheimer's disease suggests a microglial cell and immune function-related network may contribute to the disease. In Cell,... Read more...

chromoplexy cancer cell punctuated late-onset prostate rearrangement sample postmortem researcher genomic individual genome function-related GWDN brain tumor-normal Alzheimer dementia-free study disease microglial biology-based tumor gene translocations microglia immune

Consensus Outlook: Prostate Cancer – Competition intensifies in race to the top

May 22, 2013 | gnom.es

NEW YORK , May 22, 2013 /NEWS.GNOM.ES/ — Reportlinker.com announces that a new market research report is available in its catalogue: Consensus Outlook: Prostate Cancer – Competition intensifies in race to the top... Read more...

forecast prostate Cancer consensus FirstWord Outlook Therapy product intensify Trends event sale data unrivalled

image

Inexpensive, accurate way to detect prostate cancer: At-home urine tests

May 22, 2013 | cancerlive.net

After more than a decade of work, UC Irvine chemists have created a way to clearly identify clinically usable markers for prostate cancer in urine, meaning that the disease could be detected far sooner, with greater accuracy... Read more...

cancer urine prostate Irvine UC inexpensive detect test receptor marker phage Weiss 130522095819.htm

image

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer -...

May 22, 2013 | sbwire.com

New Pharmaceuticals market report from Global Markets Direct: "Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2013" ) -- 05/22/2013 -- Global Markets Direct's,... Read more...

Fast Market Research Androgen-Independent Castration Refractory Hormone Resistant Metastatic Prostate pipeline Cancer

Sipuleucel-T vs Radium-223 for Prostate Cancer

May 22, 2013 | prostate.net

Sipuleucel-T vs Radium-223 for Prostate Cancer Sipuleucel-T vs radium-223 compares two medications for late-stage castration-resistant prostate cancer. Sipuleucel-T has been available since April 2010, but now with the FDA... Read more...

Sipuleucel-T Radium-223 vs Prostate cancer medication patient

OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting

May 22, 2013 | finanznachrichten.de

BOTHELL, Wash. and VANCOUVER, British Columbia, May 22, 2013 /PRNewswire/ --OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), a leader in the development of novel therapeutics to target mechanisms of treatment resistance in... Read more...

OncoGenex OGX-427 cancer trial ASCO ORCA custirsen clinical resistance Phase treatment metastatic Hsp27 clusterin

image

Marcia Cross Stars In New PSA About Prostate Cancer With The Safeway Foundation And Stand Up To...

May 22, 2013 | finanznachrichten.de

LOS ANGELESand NEW YORK, May 22, 2013 /PRNewswire-USNewswire/ --The Safeway Foundation and Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation (EIF), have teamed up to develop a print, radio and... Read more...

Safeway SU2C prostate cancer Foundation Marcia Cross PSA Stand Up EIF research

image

More comparative effectiveness goodness

May 22, 2013 | theincidentaleconomist.com

In this week’s JAMA Internal Medicine, “Comparative Effectiveness of Intensity-Modulated Radiotherapy and Conventional Conformal Radiotherapy in the Treatment of Prostate Cancer After Radical Prostatectomy“: Importance... Read more...

radiotherapy IMRT CRT comparative effectiveness prostatectomy radiation therapy conformal patient morbidity recurrent postprostatectomy vs.

Pricey Radiation no Better Post Prostatectomy

May 21, 2013 | nih.gov

Men who get an older and less costly form of radiation after their cancerous prostates are removed fare just as well as men who get a new and expensive type of radiation, according to a new study. Source: Reuters Health Related... Read more...

IMRT radiation prostate CRT patient cancer Chen study

image

Paulsen Should Investigate Medical Company With 87% Profit

May 21, 2013 | mnpoliticalroundtable.com

If you are a man, you wonder about prostate cancer. Should you have the prostate-specific antigen (PSA) test ? If you are a woman, you wonder about breast cancer. Should you have a test for BRCA1 or to a related gene BRCA2 ?... Read more...

Mncentral Paulsen BRCA MDET test Myriad 87 Genetics BRCA1 medical testing gene PSA profit cancer cnfqtj Life Technologies Erik

image

Ease Cancer Stress, Anxiety with ‘Emotional Wellness Toolbox’

May 21, 2013 | ottawalife.com

Pioneering Psychotherapist Shares 3 Strategies that Work A not-so-surprising new study shows stress reduces the effectiveness of drugs on prostate cancer, and even accelerates the disease’s development. “More than 150 million... Read more...
All similar articles: 113 »

cancer anxiety toolbox stress Wellness Barr treatment emotional patient ease www.canceremotionalwellbeing.com

News From Annals Of Internal Medicine, May 21, 2013

May 22, 2013 | medilexicon.com

MediLexicon - Found 2 hours ago ... news headlines printer friendly Main Category: Also Included In: Dermatology | | Article Date: 22 May 20131. Older, Sicker Men Unlikely to Benefit from Aggressive Therapy for Newly Diagnosed... Read more...

DSM-5 ulcer patient prostate Difficile www.annals.org fecal oxandrolone 10.7326 Llink article.aspx?doi cancer TPUs diagnosis nasogastric therapy microbiota comorbid DSM-IV placebo

Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion...

May 22, 2013 | bio-medicine.org

BUFFALO, N.Y. , May 22, 2013 /- Empire Genomics announced today it has acquired an exclusive license for a patent pending novel genomic biomarker from Cornell University for use in developing a molecular diagnostic test that... Read more...

NEPC Genomics diagnosing empire prostate novel PCA license Cornell neuroendocrine molecular patient Commercialization cancer CCTEC

Revised sunscreen labels should help consumers make wiser choices

May 21, 2013 | kfvs12.com

Favorite music may ease anxiety for patients Favorite music may ease anxiety for patients Music can help soothe the fear and anxiety of critically ill patients who have been placed on ventilators, reducing both their stress and... Read more...
All similar articles: 294 »

sunscreen cancer SPF label disparity study lung sun skin wise non-small Racial revised choice FDA dermatologist melanoma

image

Accuray touts CyberKnife study

May 22, 2013 | auntminnie.com

May 22, 2013 -- Radiation oncology firm Accuray said that a large study using its CyberKnife robotic radiosurgery system validated use of the technology for prostate cancer treatment. To view the remainder of this article, and... Read more...

CyberKnife Accuray study prostate intermediate-risk patient radiation treatment

image

Age, Other Illnesses May Make Prostate Cancer Treatment Unnecessary

May 21, 2013 | ivillage.com

For older patients with hypertension, heart failure, different problems will likely cause death, study finds TUESDAY, May 21 (HealthDay News) -- Aggressive treatment for prostate cancer may not be warranted for many older... Read more...
All similar articles: 139 »

prostate cancer Daskivich treatment risk 14-year dying study patient

image

Medivation's CEO Presents at UBS Global Healthcare Conference (Transcript)

May 21, 2013 | seekingalpha.com

Executives David T. Hung - Chief Executive Officer, President and Executive Director Analysts Matthew Roden - UBS Investment Bank, Research Division Medivation, Inc. UBS Global Healthcare Conference May 20, 2013 1:00 PM ET... Read more...

XTANDI patient pre-chemo ZYTIGA trial PREVAIL Medivation post-chemo prostate placebo indiscernible drug Casodex Lupron transcript Astellas cancer survival

Researchers Discover Prostate Cancer-Fighting Compound in Jamaican Allspice

May 21, 2013 | healthcanal.com

Essential to jerk seasoning, allspice is known for flavoring Jamaican and other cuisines around the world with a blend of cinnamon, cloves, nutmeg and pepper but, according to a new study by Miller School researchers, the... Read more...

allspice Lokeshwar Ericifolin prostate cancer Nagarajarao anticancer compound Jamaican

Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life...

May 21, 2013 | ro-journal.com

Alan J Katz, Michael Santoro, Fred Diblasio and Richard Ashley Background Stereotactic body radiotherapy (SBRT) may yield disease control for prostate cancer in a brief, hypofractionated treatment regimen without increasing... Read more...

Alan J Katz 36.25?Gy Stereotactic 35?Gy patient prostate radiotherapy toxicity urinary QOL Grade cancer dose rectal disease biochemical SBRT PSA